Regeneron Pharmaceuticals REGN Ratios (2009-2026)

NASDAQ REGN
$827.72 -15.75 (-1.87%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Regeneron Pharmaceuticals Quarterly Ratios

Periods 69 quarters
Latest Jun 2026

Regeneron Pharmaceuticals reported a gross margin of 91.59% and a net margin of 30.23% for the quarter ended Jun 2026. These financial ratios cover 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
93.08%83.61%93.01%94.78%93.99%-178.00%92.12%93.27%93.32%92.47%92.36%92.73%92.95%91.38%91.23%92.50%92.52%91.80%89.64%91.59%
EBT Margin
52.61%50.56%35.79%33.71%51.42%1,324.70%27.13%34.29%33.03%33.42%22.28%45.90%40.13%25.29%29.88%41.32%46.97%26.87%23.05%35.61%
EBIT Margin
53.50%53.31%42.44%38.85%41.68%1,146.80%29.94%32.19%33.04%28.33%23.89%30.15%31.70%26.13%19.54%29.37%27.35%22.65%17.83%30.15%
EBITDA Margin
53.50%53.31%42.44%38.85%41.68%1,146.80%29.94%32.19%33.04%28.33%23.89%30.15%31.70%26.13%19.54%29.37%27.35%22.65%17.83%30.15%
Operating Margin
53.50%53.31%42.44%38.85%41.68%1,146.80%29.94%32.19%33.04%28.33%23.89%30.15%31.70%26.13%19.54%29.37%27.35%22.65%17.83%30.15%
Net Margin
47.27%45.01%32.83%29.82%44.81%1,197.10%25.86%30.66%29.97%33.77%22.96%40.38%36.03%24.22%26.70%37.86%38.89%21.74%20.17%30.23%
FCF Margin
95.01%44.78%66.10%14.38%16.57%1,567.70%37.61%35.63%21.49%24.41%43.83%9.48%23.83%44.01%26.94%25.18%37.75%42.26%23.53%13.35%
Efficiency
Inventory AverageInventory Avg.
2.02B2.00B1.97B2.10B2.32B2.41B2.41B2.47B2.53B2.57B2.65B2.79B2.95B3.05B3.14B3.20B3.23B3.23B3.15B3.09B
Assets AverageAssets Avg.
22.58B24.55B25.89B26.78B27.44B28.45B29.64B30.36B31.41B32.62B33.72B35.23B36.76B37.60B37.65B37.88B39.19B40.36B40.71B41.30B
Invested CapitalInvested Cap.
19.24B20.75B21.90B22.67B23.42B24.65B25.48B26.00B26.89B27.96B28.97B30.19B31.31B31.34B31.37B31.92B32.94B33.24B33.41B33.70B
Asset Utilization RatioAsset Util.
0.600.650.640.530.500.310.310.310.310.400.390.380.380.380.370.380.360.360.370.38
Leverage & Solvency
Interest Coverage RatioInterest Cover
130.08187.2192.5484.7379.9865.9152.5953.7862.4253.1646.6772.2785.4794.3068.01299.8653.2072.1249.84117.59
Debt Ratio
0.080.080.080.070.070.070.070.060.060.060.060.050.050.050.050.050.050.050.050.05
Times Interest Earned
130.08187.2192.5484.7379.9865.9152.5953.7862.4253.1646.6772.2785.4794.3068.01299.8653.2072.1249.84117.59
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
8.6215.0316.019.117.4413.40
FCF Payout RatioFCF Cover
0.110.100.060.060.120.17
Dividend YieldDiv. Yield
0.14%0.17%0.16%0.11%0.12%0.15%
Payout Ratio
0.120.070.060.110.130.07
Valuation
Price to EarningsP/E
46.2035.7591.5489.0155.9764.55107.6179.3986.8080.82143.7179.3284.7783.7583.6839.6539.9095.59110.5049.43
Price to SalesP/S
21.8416.1030.0626.5425.08772.7227.8324.3426.0227.2932.9932.0330.5420.2822.3415.0115.5220.7922.2914.94
Price to BookP/B
4.374.254.483.673.433.413.753.203.513.613.844.033.882.622.301.841.882.582.562.02
Enterprise Value
69.62B74.00B82.07B68.28B66.62B69.53B79.04B67.96B77.57B82.87B93.24B103.81B103.84B67.85B59.32B47.71B49.81B72.13B71.60B56.11B
EV to EBIT
37.6928.0365.2161.5254.4460.6383.4966.8569.8285.18124.0897.0588.0468.52100.2644.1948.5181.98111.3743.37
EV to EBITDA
37.6928.0365.2161.5254.4460.6383.4966.8569.8285.18124.0897.0588.0468.52100.2644.1948.5181.98111.3743.37
Market Capitalization
75.41B79.70B89.12B75.84B73.64B77.27B88.00B76.88B87.48B93.71B103.76B113.62B113.64B76.86B67.67B55.18B58.25B80.74B80.35B64.10B
Price to FCFP/FCF
22.9935.9445.47184.62151.4049.2973.9968.33121.08111.7975.26337.84128.1946.0982.9559.6341.1049.1894.72111.91
EV to FCF
21.2233.3741.87166.20136.9644.3566.4560.39107.3698.8567.63308.67117.1440.6972.7251.5535.1443.9484.4197.95
EV to CFO
20.3931.1939.05120.97105.9340.4357.8066.4769.6176.0561.64293.2480.4253.7356.7641.6930.7761.6166.3669.01
Return Ratios
Return on Sales [ROS]ROS
53.50%53.31%42.44%38.85%41.68%1,146.80%29.94%32.19%33.04%28.33%23.89%30.15%31.70%26.13%19.54%29.37%27.35%22.65%17.83%30.15%
Return on Capital Employed [ROCE]ROCE
39.62%43.39%39.73%28.87%25.37%18.73%16.68%15.90%15.18%13.86%12.78%12.31%12.00%11.86%11.24%11.23%10.61%9.94%10.19%10.74%
Return on Invested Capital [ROIC]ROIC
35.76%38.75%37.04%27.58%24.05%17.61%15.87%15.16%14.56%13.90%12.91%12.44%12.10%11.76%11.03%11.10%10.12%9.31%9.34%9.60%
Return on Assets [ROA]ROA
30.98%32.89%30.64%21.24%19.57%15.25%14.11%14.16%12.71%12.12%11.44%12.27%12.66%11.74%11.95%11.77%11.68%11.16%10.86%10.48%